1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity - PubMed (original) (raw)
. 2015 Aug 7;13(29):8016-28.
doi: 10.1039/c5ob00751h. Epub 2015 Jun 29.
Affiliations
- PMID: 26118967
- DOI: 10.1039/c5ob00751h
1,8-Naphthalimide derivatives: new leads against dynamin I GTPase activity
Mohammed K Abdel-Hamid et al. Org Biomol Chem. 2015.
Abstract
Fragment-based in silico screening against dynamin I (dynI) GTPase activity identified the 1,8-naphthalimide framework as a potential scaffold for the design of new inhibitors targeting the GTP binding pocket of dynI. Structure-based design, synthesis and subsequent optimization resulted in the development of a library of 1,8-naphthalimide derivatives, called the Naphthaladyn™ series, with compounds 23 and 29 being the most active (IC50 of 19.1 ± 0.3 and 18.5 ± 1.7 μM respectively). Compound 29 showed effective inhibition of clathrin-mediated endocytosis (IC50(CME) 66 μM). The results introduce 29 as an optimised GTP-competitive lead Naphthaladyn™ compound for the further development of naphthalimide-based dynI GTPase inhibitors.
Similar articles
- Development of quinone analogues as dynamin GTPase inhibitors.
MacGregor KA, Abdel-Hamid MK, Odell LR, Chau N, Whiting A, Robinson PJ, McCluskey A. MacGregor KA, et al. Eur J Med Chem. 2014 Oct 6;85:191-206. doi: 10.1016/j.ejmech.2014.06.070. Epub 2014 Jul 5. Eur J Med Chem. 2014. PMID: 25084145 - The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening.
Odell LR, Howan D, Gordon CP, Robertson MJ, Chau N, Mariana A, Whiting AE, Abagyan R, Daniel JA, Gorgani NN, Robinson PJ, McCluskey A. Odell LR, et al. J Med Chem. 2010 Jul 22;53(14):5267-80. doi: 10.1021/jm100442u. J Med Chem. 2010. PMID: 20575553 - Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.
Odell LR, Abdel-Hamid MK, Hill TA, Chau N, Young KA, Deane FM, Sakoff JA, Andersson S, Daniel JA, Robinson PJ, McCluskey A. Odell LR, et al. J Med Chem. 2017 Jan 12;60(1):349-361. doi: 10.1021/acs.jmedchem.6b01422. Epub 2016 Dec 20. J Med Chem. 2017. PMID: 27997171 - Dynamin GTPase, a force-generating molecular switch.
Warnock DE, Schmid SL. Warnock DE, et al. Bioessays. 1996 Nov;18(11):885-93. doi: 10.1002/bies.950181107. Bioessays. 1996. PMID: 8939066 Review. - Naphthalimide derivatives with therapeutic characteristics: a patent review.
Kamal A, Bolla NR, Srikanth PS, Srivastava AK. Kamal A, et al. Expert Opin Ther Pat. 2013 Mar;23(3):299-317. doi: 10.1517/13543776.2013.746313. Epub 2013 Feb 1. Expert Opin Ther Pat. 2013. PMID: 23369185 Review.
Cited by
- A comprehensive review of flow chemistry techniques tailored to the flavours and fragrances industries.
Gambacorta G, Sharley JS, Baxendale IR. Gambacorta G, et al. Beilstein J Org Chem. 2021 May 18;17:1181-1312. doi: 10.3762/bjoc.17.90. eCollection 2021. Beilstein J Org Chem. 2021. PMID: 34136010 Free PMC article. Review. - Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection.
Alkafaas SS, Abdallah AM, Ghosh S, Loutfy SA, Elkafas SS, Abdel Fattah NF, Hessien M. Alkafaas SS, et al. Rev Med Virol. 2023 Jan;33(1):e2403. doi: 10.1002/rmv.2403. Epub 2022 Nov 7. Rev Med Virol. 2023. PMID: 36345157 Free PMC article. Review. - Synthesis of Phthaladyn-29 and Naphthalimide-10, GTP Site Directed Dynamin GTPase Inhibitors.
Russell CC, Prichard KL, O'Brien NS, McCluskey A, Robinson PJ, Baker JR. Russell CC, et al. Methods Mol Biol. 2022;2417:239-258. doi: 10.1007/978-1-0716-1916-2_18. Methods Mol Biol. 2022. PMID: 35099804 - The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models.
Odell LR, Jones NC, Chau N, Robertson MJ, Ambrus JI, Deane FM, Young KA, Whiting A, Xue J, Prichard K, Daniel JA, Gorgani NN, O'Brien TJ, Robinson PJ, McCluskey A. Odell LR, et al. RSC Med Chem. 2023 Apr 26;14(8):1492-1511. doi: 10.1039/d2md00371f. eCollection 2023 Aug 16. RSC Med Chem. 2023. PMID: 37593570 Free PMC article. - The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.
Szewczyk-Roszczenko OK, Roszczenko P, Shmakova A, Finiuk N, Holota S, Lesyk R, Bielawska A, Vassetzky Y, Bielawski K. Szewczyk-Roszczenko OK, et al. Cells. 2023 Sep 19;12(18):2312. doi: 10.3390/cells12182312. Cells. 2023. PMID: 37759535 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources